Library — CHDR

Search

Filter

Clearance of plasminogen activator--a major determinant of plasma concentration: therapeutic and diagnostic implications.

Cohen AF, Burggraaf K, de Boer A, Kluft C

Annals of the New York Academy of Sciences, 2018 Dec

View publication
Assessment of changes in liver blood flow after food intake--comparison of ICG clearance and echo-Doppler.

Burggraaf J, Schoemaker HC, Cohen AF

British journal of clinical pharmacology, 2018 Dec; 42(4):499-502

View publication
Recombinant human erythropoietin does not affect several microvascular parameters in well-trained cyclists.

Birkhoff WAJ, Heuberger JAAC, Post TE, Gal P, Stuurman FE, Burggraaf J, Cohen AF

Physiological reports, 2018 Dec; 6(24):e13924

View publication
Retinal microcirculation imaging in sickle cell disease patients.

Birkhoff W, de Vries J, Dent G, Verma A, Kerkhoffs JL, van Meurs AHF, de Kam M, Moerland M, Burggraaf J

Microvascular research, 2018 Mar

View publication
Levofloxacin-Induced QTc Prolongation Depends on the Time of Drug Administration.

Kervezee L, Gotta V, Stevens J, Birkhoff W, Kamerling I, Danhof M, Meijer JH, Burggraaf J

CPT: pharmacometrics & systems pharmacology, 2016 Aug; 5(9):466-74

View publication
A PK-PD model-based assessment of sugammadex effects on coagulation parameters.

Bosch R, van Lierop MJ, de Kam PJ, Kruithof AC, Burggraaf J, de Greef R, Visser SA, Johnson-Levonas AO, Kleijn HJ

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2016 Mar

View publication
Digoxin and mortality: lessons for observational studies.

de Boer A, Cohen AF

British journal of clinical pharmacology, 2015 Dec; 81(1):4-5

View publication
A single infusion of MDCO-216 (ApoA-1 Milano/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery disease.

Kallend DG, Reijers JA, Bellibas SE, Bobillier A, Kempen H, Burggraaf J, Moerland M, Wijngaard PL

European heart journal. Cardiovascular pharmacotherapy, 2015 Dec; 2(1):23-9

View publication
Antisense MicroRNA Therapeutics in Cardiovascular Disease: Quo Vadis?

Philippen LE, Dirkx E, Wit JB, Burggraaf K, de Windt LJ, da Costa Martins PA

Molecular therapy : the journal of the American Society of Gene Therapy, 2015 Dec; 23(12):1810-8

View publication

«
1
2
3
4
5
6
7
8
...
12
13
»